These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7825572)

  • 1. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.
    Winnard AV; Mendell JR; Prior TW; Florence J; Burghes AH
    Am J Hum Genet; 1995 Jan; 56(1):158-66. PubMed ID: 7825572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin.
    Thanh LT; Nguyen TM; Helliwell TR; Morris GE
    Am J Hum Genet; 1995 Mar; 56(3):725-31. PubMed ID: 7887428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon skipping and translation in patients with frameshift deletions in the dystrophin gene.
    Sherratt TG; Vulliamy T; Dubowitz V; Sewry CA; Strong PN
    Am J Hum Genet; 1993 Nov; 53(5):1007-15. PubMed ID: 8213828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
    Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
    JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
    Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W
    Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.
    van Deutekom JC; Bremmer-Bout M; Janson AA; Ginjaar IB; Baas F; den Dunnen JT; van Ommen GJ
    Hum Mol Genet; 2001 Jul; 10(15):1547-54. PubMed ID: 11468272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers.
    Klein CJ; Coovert DD; Bulman DE; Ray PN; Mendell JR; Burghes AH
    Am J Hum Genet; 1992 May; 50(5):950-9. PubMed ID: 1570844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy.
    Nicholson LV
    Neuromuscul Disord; 1993; 3(5-6):525-31. PubMed ID: 8186705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular deletion patterns in Turkish Duchenne and Becker muscular dystrophy patients.
    Dinçer P; Topaloğlu H; Ayter S; Ozgüç M; Taşdemir HA; Renda Y
    Brain Dev; 1996; 18(2):91-4. PubMed ID: 8733896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
    Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE
    Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
    J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases.
    Ousterout DG; Kabadi AM; Thakore PI; Perez-Pinera P; Brown MT; Majoros WH; Reddy TE; Gersbach CA
    Mol Ther; 2015 Mar; 23(3):523-32. PubMed ID: 25492562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy.
    Hagiwara Y; Nishio H; Kitoh Y; Takeshima Y; Narita N; Wada H; Yokoyama M; Nakamura H; Matsuo M
    Am J Hum Genet; 1994 Jan; 54(1):53-61. PubMed ID: 8279470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
    Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation.
    Wilton SD; Johnsen RD; Pedretti JR; Laing NG
    Am J Med Genet; 1993 Jun; 46(5):563-9. PubMed ID: 8322822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a dystrophin gene deletion by amplification of mRNA isolated from DMD myotubes cultured in vitro.
    Ehrenpreis J; Hillers M; Junkes B; Pfordt M; Schwinger E; Vosberg HP
    Genomics; 1991 Jul; 10(3):551-7. PubMed ID: 1889805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
    Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD
    PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.
    Nguyen TM; Morris GE
    Am J Hum Genet; 1993 Jun; 52(6):1057-66. PubMed ID: 7684887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion.
    Lu QL; Morris GE; Wilton SD; Ly T; Artem'yeva OV; Strong P; Partridge TA
    J Cell Biol; 2000 Mar; 148(5):985-96. PubMed ID: 10704448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.